Instituto de Biomedicina de Sevilla -ko ikertzaileekin lankidetzan egindako argitalpenak (5)

2022

  1. Involvement of the Substance P/Neurokinin-1 Receptor System in Cancer

    Cancers

  2. Why Use Aprepitant Only as a Cough Suppressant in Lung Cancer When at Higher Doses it Could Also Exert an Antitumor Action?

    Archivos de Bronconeumologia

2019

  1. Antipruritic vs. Antitumour action of aprepitant: A question of dose

    Acta Dermato-Venereologica

2015

  1. Targeting NK-1 receptors to prevent and treat pancreatic cancer: A new therapeutic approach

    Cancers, Vol. 7, Núm. 3, pp. 1215-1232

2014

  1. Antitumor activity of neurokinin-1 receptor antagonists in MG-63 human osteosarcoma xenografts

    International Journal of Oncology, Vol. 44, Núm. 1, pp. 137-146